Search

everythinglearnresearchcommunity

for

Search:↓

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

High prolactin levels might be linked to hair loss in autoimmune thyroid disease, but more research is needed.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Tattoos may trigger autoimmune symptoms in some people.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

Hair disorders in organ transplant patients are often underestimated and need more attention and research.

Heavy metals like arsenic, cadmium, and lead can increase cancer risk and worsen outcomes.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

No treatment fully prevents hair loss from chemotherapy yet.

Indigenous herbal medicines in the Indian subcontinent have potential for drug development but need more research and standardization.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

The laser treatment effectively and safely improved keratosis pilaris.

Advancements in cultured models improve understanding and treatment of gallbladder cancer.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Neurosteroids show promise for treating epilepsy and more research is needed.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.